A detailed history of Pallas Capital Advisors LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 4,203 shares of PTCT stock, worth $201,155. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,203
Previous 6,925 39.31%
Holding current value
$201,155
Previous $375,000 45.33%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 09, 2025

SELL
$36.19 - $52.13 $98,509 - $141,897
-2,722 Reduced 39.31%
4,203 $205,000
Q1 2025

Apr 14, 2025

BUY
$41.81 - $57.17 $289,534 - $395,902
6,925 New
6,925 $375,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.42B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.